Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation (SCT)”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Not applicableStudy completedNCT03959007
What this trial is testing

Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases

Who this might be right for
Acute LeukemiaHematopoietic Stem Cell Transplantation (SCT)Aplasia
University Hospital, Lille 70
Testing effectiveness (Phase 2)Ended earlyNCT02504619
What this trial is testing

Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia
Gamida Cell ltd 1
Testing effectiveness (Phase 2)Ended earlyNCT01279616
What this trial is testing

A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Nationwide Children's Hospital 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199
What this trial is testing

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 100
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Not applicableStudy completedNCT00861679
What this trial is testing

Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International

Who this might be right for
Acute Lymphoblastic Leukemia
Hadassah Medical Organization 552
Testing effectiveness (Phase 2)Study completedNCT00580034
What this trial is testing

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 176
Large-scale testing (Phase 3)Ended earlyNCT04161885
What this trial is testing

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Cancer
AbbVie 465
Early research (Phase 1)Study completedNCT01041508
What this trial is testing

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

Who this might be right for
Leukemia Lymphoblastic, AcuteAcute Myeloid LeukemiaNeoplasm Recurrent
Therapeutic Advances in Childhood Leukemia Consortium 18
Not applicableNot Yet RecruitingNCT07420790
What this trial is testing

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Who this might be right for
Acute Myeloid Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941
Testing effectiveness (Phase 2)Ended earlyNCT02619812
What this trial is testing

Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT

Who this might be right for
Multiple Myeloma
Mayo Clinic 4
Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Testing effectiveness (Phase 2)Ended earlyNCT00776295
What this trial is testing

Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Early research (Phase 1)Study completedNCT01421173
What this trial is testing

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 78
Testing effectiveness (Phase 2)Looking for participantsNCT07532824
What this trial is testing

Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AMLProton Therapy+2 more
Institute of Hematology and Blood Transfusion, Czech Republic 16
Testing effectiveness (Phase 2)Ended earlyNCT02627573
What this trial is testing

Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

Who this might be right for
Leukemia, Chronic MyeloidMyelodysplastic SyndromesLeukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
St. Petersburg State Pavlov Medical University 32
Testing effectiveness (Phase 2)Study completedNCT00644371
What this trial is testing

Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 20
Large-scale testing (Phase 3)Study completedNCT00266136
What this trial is testing

Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)

Who this might be right for
Acute Myeloid Leukemia
University Hospital Muenster 3,500
Testing effectiveness (Phase 2)Study completedNCT03690115
What this trial is testing

Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients

Who this might be right for
Leukemia, Myeloid, Acute
Versailles Hospital 23
Not applicableStudy completedNCT02716103
What this trial is testing

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 45
Load More Results